Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conjugates of biologically active proteins having a modified in vivo half-life

Conjugates of biologically active proteins having a modified in vivo half-life

US Patent 8129348 · Granted Mar 6, 2012

Estimated economic value: $6,848,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2024
Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2021
Factor VIII formulations2021
Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and u2020
Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2020
Factor VIII formulations2019
Albumin-free factor VIII formulations2017
Albumin-free factor VIII formulations2016
Albumin-free factor VIII formulations2014
Conjugates of biologically active polypeptides having an increased in vivo half-2014
Conjugates of biologically active polypeptides having an increased in vivo half-2014
Conjugates of biologically active polypeptides having an increased in vivo half-2014